Home › Ovarian Epithelial Carcinoma › Utah › Salt Lake City
Ovarian Epithelial Carcinoma clinical trials in Salt Lake City, UT
5 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecruitingObservational study
- Utah Cancer Specialists, Salt Lake City
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RecruitingPhase 3
- Utah Cancer Specialists Network, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recruiting
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecruitingPhase 1/2
- START Center for Cancer Care - Mountain Region, Salt Lake City
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
RecruitingPhase 1
- LDS Hospital, Salt Lake City
Ovarian Epithelial Carcinoma trials in other cities
- Boston, MA8 studies
- Durham, NC8 studies
- New York City, NY7 studies
- San Diego, CA7 studies
- Chicago, IL7 studies
- Baltimore, MD6 studies
- Philadelphia, PA6 studies
- Cleveland, OH6 studies
- Houston, TX6 studies
- Portland, OR5 studies
- Minneapolis, MN5 studies
- Edison, NJ5 studies
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)27 studies
- Breast Cancer27 studies
- Colorectal Cancer22 studies
- Lung Cancer21 studies
- Melanoma21 studies
- Multiple Myeloma21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Obesity18 studies
- Acute Myeloid Leukemia17 studies
- Heart Failure17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.